Andog, Anna Marie .

HRN: 22-06-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2023
CEFUROXIME 1.5GM (VIAL)
05/17/2023
05/24/2023
IV
1.5 Gm
Q8
Anemia Severe Sec To PostPartum Hemorrhage; G3P3 (3003)
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: